임상시험 트래커
추적 기업 30곳의 임상 6,982건 (국내 전체 이력 · 글로벌 진행 중). 출처: ClinicalTrials.gov
기업
60건 표시 (상위 60건)
- 2상모집 예정· Primary Immune Thrombocytopenia (ITP)코르티코스테로이드 치료 실패 소아 원발성 면역혈소판감소증 환자에서 엘트롬보팍에 추가한 이아날루맙 연구
A Study of Ianalumab in Addition to Eltrombopag in Pediatric Patients With Primary ITP Who Failed Corticosteroids.
리드: 노바티스
- 2상모집 예정· PIK3CA-Related Overgrowth Spectrum (PROS)지속적 투여 및 장기 안전성을 위한 알펠리시브(BYL719) 후속 연구
Roll-Over Study of Alpelisib (BYL719) for Continued Access and Long-Term Safety.
리드: 노바티스
- 해당없음모집 예정· Referral and ConsultationOptimizing Referral Pathways for Patients With Hematuria and Moderate-Severe Proteinuria
협력: 노바티스
- 단계 미표기모집 예정· Hidradenitis SuppurativaA Study of Early Secukinumab Treatment in Moderate to Severe Hidradenitis Suppurativa Patients
리드: 노바티스
- 1상모집 예정· Recurrent Diffuse Large B-Cell LymphomaLymphodepletion With Low Dose Total Body Irradiation Before Standard of Care Tisagenlecleucel for the Treatment of Relapsed and Recurrent Large B-cell Lymphoma
협력: 노바티스
- 3상모집 예정· Acute Coronary Syndrome (ACS)Lp(a) Lowering Study of Pelacarsen (TQJ230) in Patients in the US With Elevated Lp(a) and Recent ACS (STEMI/NSTEMI) - Lp(a)FRONTIERS PEARL
리드: 노바티스
- 단계 미표기모집 예정· Complement 3 GlomerulopathyA Study of Complement 3 Glomerulopathy (C3G) Patients Treated With Iptacopan Through an Early Access Program in Spain
리드: 노바티스
- 3상모집 예정· Chronic Pruritus of Unknown OriginA Study to Evaluate Efficacy, Safety and Tolerability of Remibrutinib in Adult Participants With Severe Chronic Pruritus of Unknown Origin (CPUO)
리드: 노바티스
- 단계 미표기모집 예정· Metastatic Prostate CancerPULSE Registry: for Patients Receiving Lutetium (177Lu) Vipivotide Tetraxetan
리드: 노바티스
- 단계 미표기모집 예정· Plaque PsoriasisA Study to Estimate Secukinumab Retention Rate in Psoriasis Patients With MASLD
리드: 노바티스
- 단계 미표기모집 예정· Chronic Spontaneous UrticariaRemibrutinib in Real-world Clinical Practice - a Germany Sub-study (REASSERT)
리드: 노바티스
- 3상모집 중· Hidradenitis SuppurativaAn Extension Study to Assess Safety and Efficacy of Remibrutinib in Participants With Moderate to Severe HS
리드: 노바티스
- 1상모집 예정· Large-cell LymphomaCAR-T ceLL for Eradication of Active Residual Disease in LBCL (CLEAR-1 Study)
협력: 노바티스
- 단계 미표기모집 중· Prostatic Neoplasms, Castration-ResistantA Study of Real-World Characteristics, Treatment Patterns, and Clinical Outcomes in Patients With Metastatic Castration-Resistant Prostate Cancer
리드: 노바티스
- 2상모집 중· Anatomic Stage IV Breast Cancer AJCC v8177Lu-DOTATATE for the Treatment of Stage IV or Recurrent Breast Cancer
협력: 노바티스
- 단계 미표기모집 예정· Prostatic Neoplasms, Castration-ResistantPluvicto Real-world Investigation in Survival in Metastatic CRPC
리드: 노바티스
- 단계 미표기모집 중· Prostatic Neoplasms, Castration-ResistantA Study of Real-World Characteristics, Treatment Patterns, and Outcomes Among mCRPC Patients Previously Treated With an Androgen Receptor Pathway Inhibitor, Taxane-Based Chemotherapy, and Lutetium-177 Vipivotide Tetraxetan
리드: 노바티스
- 2상모집 예정· Multiple Sclerosis (MS) - Relapsing-remittingA Study of Remibrutinib Using MR Imaging in Relapsing or Progressive MS
협력: 노바티스
- 단계 미표기모집 예정· Chronic Myeloid LeukemiaA Study of Asciminib Safety and Efficacy in Young Adults With Chronic Myeloid Leukemia in the Gulf Region
리드: 노바티스
- 2상모집 중· Primary Immune Thrombocytopenia (ITP)A Study to Assess the Tolerability of Ianalumab (VAY736) With Investigator's Choice Thrombopoietin Receptor Agonist (IC TPO-RA) in Patients With Primary Immune Thrombocytopenia (ITP)
리드: 노바티스
- 2상모집 중· Primary Immune ThrombocytopeniaStudy of Ianalumab in Adults With Primary Immune Thrombocytopenia (ITP) and Warm-antibody Autoimmune Hemolytic Anemia (wAIHA) Who Have Previously Benefited From Ianalumab
리드: 노바티스
- 1상모집 중· Breast NeoplasmsA Phase I Study of [68Ga]Ga-DWJ155 in Patients With Breast and Lung Cancers
리드: 노바티스
- 단계 미표기모집 예정· Immune ThrombocytopeniaA Real-world Study of Treatment Patterns and Outcomes in Primary Immune Thrombocytopenia Patients Treated With Eltrombopag
리드: 노바티스
- 1상모집 중· Metastatic Pancreatic Ductal Adenocarcinoma (PDAC)Phase I Study of JFI447 [68Ga]Ga-DFC413 and Comparison to FFG233 [68Ga]Ga-NNS309 in Patients With Solid Tumors
리드: 노바티스
- 1상모집 예정· Elevated Blood PressureHJB647 Phase 1b Study in Japanese Healthy Participants With Elevated Blood Pressure and Patients With Hypertension
리드: 노바티스
- 3상모집 중· Primary Myelofibrosis (PMF)A Phase 3 Study of Pelabresib (DAK539) and Ruxolitinib in Myelofibrosis (MF)
리드: 노바티스
- 1상모집 중· Breast CancerStudy of [177Lu]Lu-DWJ155 and [68Ga]Ga-DWJ155 in Patients With Solid Tumors
리드: 노바티스
- 단계 미표기모집 예정· Leukemia, Myeloid, Chronic-PhaseA Study of Patient Characteristics, Co-Morbidities, and Treatment Patterns in Chronic Myeloid Leukemia Patients in Kuwait
리드: 노바티스
- 1/2상모집 중· Extensive-stage Small Cell Lung Cancer (ES-SCLC)A Study to Evaluate DJI136, a DLL3-targeted CAR-T Therapy
리드: 노바티스
- 단계 미표기모집 중· Paroxysmal Nocturnal HemoglobinuriaA Study of Iptacopan in Korean Patients With Paroxysmal Nocturnal Hemoglobinuria or C3 Glomerulopathy
리드: 노바티스
- 2상모집 예정· Localized Cutaneous LeishmaniasisA Clinical Trial to Investigate Efficacy, Safety and Pharmacokinetics (PK) of Two LXE408 Oral Regimens and Oral Miltefosine as Active Control in Participants Aged ≥ 18 Years Old With Localized Cutaneous Leishmaniasis in the Region of the Americas (AMR).
협력: 노바티스
- 단계 미표기모집 중· Gastroenteropancreatic Neuroendocrine TumorA Study of Treatment Patterns and Outcomes in Gastroenteropancreatic Neuroendocrine Tumor (GEP-NET) Patients
리드: 노바티스
- 1/2상모집 중· Locally Advanced or Metastatic KRAS G12C-mutated Non-small Cell Lung CancerRollover Study for Participants Who Have Been Treated With and Are Continuing to Benefit From Opnurasib as a Single Agent or in Combination With Other Study Treatments
리드: 노바티스
- 3상모집 중· Progressive Supranuclear Palsy Richardson Syndrome (PSP-RS)A Study to Evaluate the Efficacy of NIO752 in Participants With Progressive Supranuclear Palsy
리드: 노바티스
- 4상모집 중· Hidradenitis Suppurativa (HS)Study of Efficacy and Safety of Secukinumab in Chinese Adult Patients With Moderate to Severe Hidradenitis Suppurativa
리드: 노바티스
- 2상모집 중· Liver Cancer68Ga-PSMA-11 PET-directed Radioligand Therapy in Metastatic Hepatocellular Carcinoma (HCC)
협력: 노바티스
- 2상모집 예정· Cancer of Unknown PrimaryPhase II Trial of Lu-177 FAP-2286 in Patients With Carcinoma of Unknown Primary
협력: 노바티스
- 단계 미표기모집 예정· Hidradenitis SuppurativaA Real-world Study of Patients With Hidradenitis Suppurativa and High Cardiovascular Risk or Established Coronary Plaque Treated With Secukinumab
리드: 노바티스
- 1상모집 중· Advanced HR+/HER2- Breast CancerStudy of IEV407 as Single Agent or in Combination in Patients With Advanced HR+/HER2- Breast Cancer
리드: 노바티스
- 1상모집 중· Metastatic Castration-resistant Prostate Cancer (mCRPC)A Study to Investigate the Safety and Tolerability of Oral INR731 Single Agent or in Combination With Androgen Receptor Pathway Inhibitor (ARPI) in Patients With Metastatic Prostate Cancer
리드: 노바티스
- 2상초청 등록· Philadelphia Chromosome Positive Acute Lymphoblastic LeukemiaAdding Asciminib to Usual Treatment for Adults With Newly Diagnosed Philadelphia Chromosome Positive (Ph+) Acute Lymphoblastic Leukemia
협력: 노바티스
- 단계 미표기모집 중· Schnitzler SyndromeA Study to Assess the Effectiveness and Safety of Canakinumab in Clinical Use in Patients With Schnitzler's Syndrome
리드: 노바티스
- 3상모집 중· Cardiovascular Disease and Lipoprotein(a)An Open Label Extension (OLE) Study (Following Completion of CTQJ230A12301) to Evaluate Long-term Safety and Tolerability of Pelacarsen (TQJ230)
리드: 노바티스
BioPulse가 제공하는 정보는 공개된 자료를 요약·정리한 것으로, 투자 조언이나 의료 조언이 아닙니다. 임상 데이터·규제 일정·공시 내용은 반드시 원문을 직접 확인하시기 바랍니다.